Latest news for Alterity Therapeutics (OTC:PRNAF) Stock

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.

ALTERITY THERAPEUTICS LTD by Alterity Therapeutics Limited

Alterity Therapeutics Ltd

Alterity Therapeutics Ltd. (AU:ATH) has released an update. Alterity Therapeutics showcased promising results at the AAN 2024 Annual Meeting for AT...

Alterity Therapeutics Unveils Promising Neurological Data

Alterity Therapeutics Ltd. (AU:ATH) has released an update. Alterity Therapeutics has announced promising new findings for ATH434, which shows pote...

Alterity Therapeutics' Breakthrough in Rare Disease Treatment

Alterity Therapeutics Ltd. (AU:ATH) has released an update. Alterity Therapeutics Limited has announced its application for the quotation of over 7...

Alterity Therapeutics Aims for ASX Listing Boost

Alterity Therapeutics Ltd. (AU:ATH) has released an update. Alterity Therapeutics Limited reports a change in substantial holding by The Bank of Ne...

BNYMC Ups Stake in Alterity Therapeutics

Alterity Therapeutics Ltd. (AU:ATH) has released an update. JPMorgan Chase & Co. and its affiliates have ceased to be substantial holders in Alteri...

JPMorgan Chase Ends Major Stake in Alterity Therapeutics

Alterity Therapeutics Ltd. (AU:ATH) has released an update. Alterity Therapeutics Limited has announced the cessation of 5 million options due to t...

Alterity Therapeutics Announces Option Cessation

Alterity Therapeutics Ltd. (AU:ATH) has released an update. Alterity Therapeutics, a company focused on developing treatments for neurodegenerative...

Alterity Therapeutics Showcases at Life Sciences Webinar

Alterity Therapeutics Ltd. (AU:ATH) has released an update. Alterity Therapeutics Limited has announced the issuance of a substantial number of unq...

Alterity Therapeutics Issues Millions of New Options

Alterity Therapeutics Ltd. (AU:ATH) has released an update. Alterity Therapeutics Limited (ATH) has requested a trading halt pending an announcemen...

Alterity Therapeutics Halts Trading for Clinical Update

Alterity Therapeutics Ltd. (AU:ATH) has released an update. Alterity Therapeutics has announced promising interim results from its Phase 2 trial of...

Alterity's ATH434 Shows Hope in MSA Trial

PRNAF

Alterity Therapeutics

News

Intraday Update

Markets

Movers

Trading Ideas

AAGC

AAGIY

AAWC

ABCE

ABNAF

ABVC

ACAM

ACCA

ACCR

ACMC

ACRFF

AERG

AERO

AFPW

AGFAF

AGHI

AGLDF

AHELF

AINSF

AIRT

ALAN

ALPE

ALPP

ALST

AMBS

AMHPF

AMMX

AMPG

ANTH

ANXGF

APAFF

APHD

APNHY

ARAFF

AREB

ARRRF

ARYC

ARZTY

ASNT

ATDS

ATHOF

AUOTY

AVBH

AVOI

AVVH

AXTG

BABB

BANJ

BAYK

BBAVY

BBKCF

BBRRF

BCCI

BCCLF

BDVB

BEPTF

BIOIF

BIPH

BIXT

BKIRF

BKRKF

BKRKY

BLAGF

BLIAQ

BMRK

BNCC

BOLYY

BONTQ

BOTJ

BREUF

BRGGF

BRLXF

BRPHF

BRUZF

BRYN

BRZL

BSCA

BSGC

BTTR

BXNG

BXRX

BYOC

CALB

CAWW

CBAN

CBAT

CBDL

CBMJ

CBYAA

CCCGY

CCLAF

CCOHY

CDTI

CDUAF

CELZ

CESDF

CGNH

CGOL

Stocks That Hit 52-Week Lows On Tuesday

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Alterity Therapeutics

News

Latest news for Alterity Therapeutics (OTC:PRNAF) Stock

Tuesday, March 24, 2020